Latest It Compliance News

Page 135 of 355
Tivan Limited has initiated a comprehensive program of works at its recently acquired Molyhil Tungsten-Molybdenum Project, setting the stage for drilling and resource expansion in early 2026.
Maxwell Dee
Maxwell Dee
7 Nov 2025
AVITA Medical reported an 18% revenue increase in Q3 2025 driven by new product launches and deeper market penetration, while continuing to face net losses and credit covenant challenges. The company also announced a CEO departure and interim leadership appointment.
Ada Torres
Ada Torres
7 Nov 2025
Macquarie Group Limited reported a 3% increase in half-year profit to $1.655 billion, driven by growth across its asset management, banking, commodities, and capital markets divisions. The group maintains robust capital and liquidity positions despite margin pressures and regulatory challenges.
Claire Turing
Claire Turing
7 Nov 2025
Aeris Resources has completed an $80 million equity placement and launched a share purchase plan, strengthening its balance sheet and setting ambitious production targets for FY26. The company is also divesting non-core assets to focus on growth and exploration.
Maxwell Dee
Maxwell Dee
6 Nov 2025
Finexia Financial Group Limited (ASX – FNX) has had its trading suspension lifted immediately following its public response to recent media speculation. The reinstatement marks a pivotal moment for the financial group’s market activity.
Claire Turing
Claire Turing
6 Nov 2025
Finexia Financial Group has formally ended preliminary discussions with Salter Brothers regarding a potential reverse listing and is seeking immediate reinstatement of its ASX securities.
Claire Turing
Claire Turing
6 Nov 2025
ALS Limited has responded to an ASX inquiry regarding the delayed lodgement of key disclosure documents related to performance rights granted to director Malcolm Deane, attributing the delay to human error and outlining steps to reinforce compliance.
Victor Sage
Victor Sage
6 Nov 2025
James Hardie Industries faces intense scrutiny from the ASX after its share price dropped sharply and trading volumes spiked, prompting urgent questions about undisclosed information.
Victor Sage
Victor Sage
6 Nov 2025
Chimeric Therapeutics has responded to ASX inquiries regarding the disclosure timing and materiality of new clinical data from its ADVENT-AML trial, emphasizing compliance with continuous disclosure rules and the careful verification of promising patient responses.
Ada Torres
Ada Torres
6 Nov 2025
Auking Mining’s planned acquisition of Orion Resources has hit a regulatory roadblock, while Orion’s purchase of the Cloncurry Gold Project assets faces settlement delays due to vendor conditions.
Maxwell Dee
Maxwell Dee
6 Nov 2025
SportsHero Limited has voluntarily suspended trading on the ASX pending a Supreme Court decision regarding its failure to lodge required cleansing notices for recent share issues.
Sophie Babbage
Sophie Babbage
6 Nov 2025
Encounter Resources has completed the first tranche of its $25 million share placement, raising approximately $24.5 million to advance its mineral exploration projects. The second tranche, involving shares to a company director, awaits shareholder approval.
Maxwell Dee
Maxwell Dee
6 Nov 2025